Wabei.com reported on October 28 that Zhongke Meiling (835892) released a performance report for the first three quarters of 2022, achieving a revenue of 332 million yuan and a net profit of 49.17 million yuan. Among them, in the third quarter, the revenue was 96.51 million yuan, and the net profit was 7.88 million yuan.
Zhongke Meiling said that in the third quarter of this year, the company increased its investment in research and development and the market. On the one hand, focusing on the strategic layout of products, expanding the construction of the R&D team and increasing investment in R&D projects, the R&D expenses increased by 42.39% year-on-year; second, focusing on the future development plan, increasing market investment, consolidating and expanding market share, sales expenses increased by 17.77% year-on-year %.
According to the data of the Wabei Research Institute, Zhongke Meiling was established in 2002 and was jointly funded by Changhong Meiling and the Institute of Physics and Chemistry of the Chinese Academy of Sciences. Focusing on the field of life sciences, the main business is the research and development, production and sales of biomedical cryogenic storage equipment. The main products are low temperature storage refrigerators, liquid nitrogen biological containers, medical clean workbenches, biological safety cabinets, centrifuges and other equipment and services.